STIRIPENTOL: 1,350 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
1,350
Total FAERS Reports
65 (4.8%)
Deaths Reported
437
Hospitalizations
1,350
As Primary/Secondary Suspect
33
Life-Threatening
6
Disabilities
Aug 20, 2018
FDA Approved
Prescription
Status
FDA Application: 206709 ·
First Report: 19850101 · Latest Report: 20250909
What Are the Most Common STIRIPENTOL Side Effects?
#1 Most Reported
Seizure
586 reports (43.4%)
#2 Most Reported
Product use in unapproved indication
343 reports (25.4%)
#3 Most Reported
Drug ineffective
193 reports (14.3%)
All STIRIPENTOL Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Seizure | 586 | 43.4% | 8 | 223 |
| Product use in unapproved indication | 343 | 25.4% | 12 | 137 |
| Drug ineffective | 193 | 14.3% | 16 | 43 |
| Product dose omission issue | 157 | 11.6% | 3 | 65 |
| Decreased appetite | 147 | 10.9% | 1 | 46 |
| Somnolence | 139 | 10.3% | 3 | 40 |
| Product preparation issue | 129 | 9.6% | 3 | 52 |
| Off label use | 107 | 7.9% | 7 | 36 |
| Fatigue | 95 | 7.0% | 0 | 22 |
| Hospitalisation | 63 | 4.7% | 1 | 62 |
| Pyrexia | 61 | 4.5% | 6 | 28 |
| Pneumonia | 56 | 4.2% | 2 | 44 |
| Weight decreased | 54 | 4.0% | 0 | 16 |
| Condition aggravated | 50 | 3.7% | 0 | 15 |
| Change in seizure presentation | 47 | 3.5% | 4 | 10 |
| Fall | 46 | 3.4% | 1 | 13 |
| Vomiting | 44 | 3.3% | 1 | 25 |
| No adverse event | 43 | 3.2% | 0 | 7 |
| Sleep disorder | 40 | 3.0% | 0 | 6 |
| Behaviour disorder | 38 | 2.8% | 0 | 9 |
Who Reports STIRIPENTOL Side Effects? Age & Gender Data
Gender: 50.2% female, 49.8% male. Average age: 12.2 years. Most reports from: US. View detailed demographics →
Is STIRIPENTOL Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2007 | 1 | 0 | 1 |
| 2008 | 3 | 0 | 3 |
| 2009 | 3 | 0 | 1 |
| 2010 | 2 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 2 | 0 | 2 |
| 2015 | 6 | 1 | 3 |
| 2016 | 2 | 0 | 1 |
| 2017 | 12 | 0 | 5 |
| 2018 | 27 | 1 | 11 |
| 2019 | 114 | 5 | 42 |
| 2020 | 39 | 1 | 21 |
| 2021 | 50 | 3 | 26 |
| 2022 | 53 | 5 | 25 |
| 2023 | 64 | 2 | 23 |
| 2024 | 48 | 0 | 19 |
| 2025 | 25 | 2 | 9 |
What Is STIRIPENTOL Used For?
| Indication | Reports |
|---|---|
| Severe myoclonic epilepsy of infancy | 850 |
| Epilepsy | 199 |
| Product used for unknown indication | 134 |
| Lennox-gastaut syndrome | 46 |
| Seizure | 46 |
| Status epilepticus | 36 |
| Idiopathic generalised epilepsy | 34 |
| Partial seizures | 23 |
| Generalised tonic-clonic seizure | 15 |
| Epileptic encephalopathy | 13 |
STIRIPENTOL vs Alternatives: Which Is Safer?
STIRIPENTOL vs STIVARGA
STIRIPENTOL vs STRATTERA
STIRIPENTOL vs STREPTOCOCCUS PNEUMONIAE TYPE 1 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 14 CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 18C CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 19A CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN\STREPTOCOCCUS PNEUMONIAE TYPE 19F CAPSULAR POLYSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE A
STIRIPENTOL vs STREPTOMYCIN
STIRIPENTOL vs STREPTOMYCIN\STREPTOMYCIN
STIRIPENTOL vs STREPTOZOCIN
STIRIPENTOL vs STRIBILD
STIRIPENTOL vs SUBOXONE
STIRIPENTOL vs SUBUTEX
STIRIPENTOL vs SUCCINYLCHOLINE
Official FDA Label for STIRIPENTOL
Official prescribing information from the FDA-approved drug label.